Psyched Wellness Ltd. (CSE:PSYC) (OTCQB:PSYCF) (FRA:5U9) advisor and psychopharmacolost Dr David Nutt describes to Proactive why the group is focusing on harnessing the Amanita Muscaria mushroom.
Dr Nutt, who has pioneered research on psilocybin mushrooms over the last 15 years, says the mushroom has potential benefits for people suffering from serious mental and physical health issues. He's looking forward to the group's pre-clinical trials focusing on Amanita Muscaria extract, AME-1.